Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 4
1988 1
1990 3
1992 1
1997 1
2002 1
2009 1
2016 2
2018 3
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

19 results
Results by year
Filters applied: . Clear all
Page 1
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
De Laere B, Oeyen S, Mayrhofer M, Whitington T, van Dam PJ, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert EG, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff IE, van Dam V, Brouwer A, Goossens D, Heyrman L, Van den Eynden GG, Rutten A, Del Favero J, Rantalainen M, Rajan P, Sleijfer S, Ullén A, Yachnin J, Grönberg H, Van Laere SJ, Lindberg J, Dirix LY. De Laere B, et al. Among authors: van oyen p. Clin Cancer Res. 2019 Mar 15;25(6):1766-1773. doi: 10.1158/1078-0432.CCR-18-1943. Epub 2018 Sep 12. Clin Cancer Res. 2019. PMID: 30209161 Free PMC article. Clinical Trial.
Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.
De Laere B, Oeyen S, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, Van Kerckhove P, De Maeseneer D, Strijbos M, Bols A, Fransis K, Beije N, de Kruijff I, van Dam V, Brouwer A, van Dam PJ, Van den Eynden G, Rutten A, Sleijfer S, Vandebroek J, Van Laere S, Dirix L. De Laere B, et al. Among authors: van oyen p. Prostate. 2018 May;78(6):435-445. doi: 10.1002/pros.23488. Epub 2018 Feb 12. Prostate. 2018. PMID: 29431193
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.
Mayrhofer M, De Laere B, Whitington T, Van Oyen P, Ghysel C, Ampe J, Ost P, Demey W, Hoekx L, Schrijvers D, Brouwers B, Lybaert W, Everaert E, De Maeseneer D, Strijbos M, Bols A, Fransis K, Oeyen S, van Dam PJ, Van den Eynden G, Rutten A, Aly M, Nordström T, Van Laere S, Rantalainen M, Rajan P, Egevad L, Ullén A, Yachnin J, Dirix L, Grönberg H, Lindberg J. Mayrhofer M, et al. Among authors: van oyen p. Genome Med. 2018 Nov 21;10(1):85. doi: 10.1186/s13073-018-0595-5. Genome Med. 2018. PMID: 30458854 Free PMC article.
Postoperative spindle cell nodule of bladder.
Vekemans K, Vanneste A, Van Oyen P, Michielssen P, Denys H, Vergison R. Vekemans K, et al. Among authors: van oyen p. Urology. 1990 Apr;35(4):342-4. doi: 10.1016/0090-4295(90)80161-f. Urology. 1990. PMID: 2321329
Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study.
van den Driessche H, Mattelaer P, van Oyen P, Marchand W, Bar-Moshé O, Merckx L, Billiet I, Cabri P, Maisonobe P, De Ruyter V, Braeckman J. van den Driessche H, et al. Among authors: van oyen p. Drugs Real World Outcomes. 2016 May 13;3(2):183-190. doi: 10.1007/s40801-016-0074-5. eCollection 2016 Jun. Drugs Real World Outcomes. 2016. PMID: 27398297 Free PMC article.
Primary osteogenic sarcoma of the bladder.
Van Oyen PM, Bergmans G, Denys H, Vergison R. Van Oyen PM, et al. Acta Urol Belg. 1987;55(3):380-2. Acta Urol Belg. 1987. PMID: 3477942 No abstract available.
19 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page